Results 11 to 20 of about 4,283,849 (254)

Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction

Biomolecules, 2023
Vitamin D emerged as an important prognostic biomarker in heart failure (HF), with currently highly debated therapeutic implications. Several trials on vitamin D supplementation in HF showed improvements in left ventricular (LV) remodeling and function ...
Timea Magdolna Szabo, Előd Ernő Nagy, Ádám Kirchmaier, Erhard Heidenhoffer, Hunor-László Gábor-Kelemen, Marius Frăsineanu, Judit Cseke, Márta Germán-Salló, Attila Frigy   +8 more
doaj   +2 more sources

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure

Arquivos Brasileiros de Cardiologia
Heart failure predisposes to an increased risk of silent cerebral infarction, and data related to left ventricular ejection fraction are still limited.
Márcia Maria Carneiro Oliveira, Elieusa e Silva Sampaio, Jun Ramos Kawaoka, Maria Amélia Bulhões Hatem, Edmundo José Nassri Câmara, André Maurício Souza Fernandes, Jamary Oliveira-Filho, Roque Aras   +7 more
doaj   +2 more sources

Heart failure with midrange ejection fraction: Prior left ventricular ejection fraction and prognosis [PDF]

, 2021
Evidence-based guidelines for heart failure management depend mainly on current left ventricular ejection fraction (LVEF). However, fewer studies have examined the impact of prior LVEF. Patients may enter the heart failure with midrange ejection fraction
Zhang, Yanli, Tse, Gary, Liu, Ying, Sun, Yuxi, Chen, Feifei, Song, Shuang, He, Hongyan, Zhang, Shuyuan, Zhang, Xinxin   +8 more
core   +1 more source

Efficacy of guideline-directed medical treatment in heart failure with mildly reduced ejection fraction. [PDF]

, 2022
Heart failure with mildly reduced ejection fraction (HFmrEF) has received increasing attention following the publication of the latest ESC guidelines in 2021.
Zhang, Yunlong, Yu, Songqi, Zhang, Yanli, Tse, Gary, Liu, Ying, Sun, Yuxi, Sha, Qiuyan, Ding, Zijie, Wang, Ning, Zhang, Xinxin, Lv, Xin   +10 more
core   +1 more source

Exercise training in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis [PDF]

, 2022
Background While exercise training (ET) is an established tool in heart failure (HF), no research to date has analysed the efficacy of ET in both preserved (HFpEF) and reduced (HFrEF) ejection fraction phenotypes across the same clinically important ...
O'Driscoll, J., Edwards, J.
core   +1 more source

The value of IGF-1 and IGFBP-1 in patients with heart failure with reduced, mid-range, and preserved ejection fraction [PDF]

, 2022
Background: Previous studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF).
Tse, Gary, Liu, Tong, Gong, Mengqi, Li, Guangping, Chen, Kang-Yin, Guo, Shaohua   +5 more
core   +1 more source

Reverse atrial remodeling in heart failure with recovered ejection fraction [PDF]

, 2023
Background Heart failure with recovered ejection fraction (HFrecEF) has been a newly recognized entity since 2020. However, the concept has primarily focused on left ventricular ejection fraction improvement, with less focus on the recovery of the left ...
Yunlong Xia, Yanli Zhang, Jinping Si, Xinxin Zhang, Xuefu Chen, Gary Tse, Ying Liu, Yuxi Sun, Yao Yu, Zijie Ding   +9 more
core   +1 more source

Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction [PDF]

, 2021
Aims There is an emerging interest in elucidating the natural history and prognosis for patients with heart failure with reduced ejection fraction (HFrEF) in whom left ventricular ejection fraction (LVEF) subsequently improves.
Zhang, Yanli, Liu, Ying, Sun, Yuxi, Chen, Feifei, Xia, Yunlong, Yang, Jing, Li, Xiao, Li, Jiaxin, Zhang, Xinxin, Dai, Mengyuan, Si, Jinping, Tse, G.   +11 more
core   +1 more source

Empagliflozin in patients with heart failure, reduced ejection fraction, and volume overload EMPEROR-Reduced trial [PDF]

, 2021
Background: Investigators have hypothesized that sodium-glucose cotransporter 2 (SGLT2) inhibitors exert diuretic effects that contribute to their ability to reduce serious heart failure events, and this action is particularly important in patients ...
Joao Pedro Ferreira, Martina Brueckmann, Daniel Cotton, Milton Packer, Javed Butler, Anker, Stefan D, Faiez Zannad, Zannad, Faiez, Gerasimos Filippatos, Filippatos, Gerasimos, Brueckmann, Martina, EMPEROR-Reduced Trial Committees and Investigators, Anker, Stefan, D, Cotton, Daniel, Pocock, Stuart, J, Stefan D. Anker, Pocock, Stuart,, Butler, Javed, Ferreira, João,, Jamal, Waheed, Ferreira, Joao Pedro, Stuart J. Pocock, Sattar, Naveed, Pocock, Stuart J, Tomoko Iwata, Anker, Stefan D., Naveed Sattar, Anker, Stefan,, Packer, Milton, Waheed Jamal, Pocock, Stuart J., Iwata, Tomoko, Ferreira, João, Pedro   +32 more
core   +3 more sources

Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction

ESC Heart Failure, 2021
Aims Congestive heart failure (CHF) and impaired renal function are two often co‐existing medical conditions and associated with adverse cardiovascular outcome.
Susanne Jung, Agnes Bosch, Julie Kolwelter, Kristina Striepe, Dennis Kannenkeril, Tizia Schuster, Christian Ott, Stephan Achenbach, Roland E. Schmieder   +8 more
doaj   +1 more source